NO20024011D0 - Karbohydratformulering (prebiotisk hjelpemiddel) for å forbedre immunforsvaret - Google Patents

Karbohydratformulering (prebiotisk hjelpemiddel) for å forbedre immunforsvaret

Info

Publication number
NO20024011D0
NO20024011D0 NO20024011A NO20024011A NO20024011D0 NO 20024011 D0 NO20024011 D0 NO 20024011D0 NO 20024011 A NO20024011 A NO 20024011A NO 20024011 A NO20024011 A NO 20024011A NO 20024011 D0 NO20024011 D0 NO 20024011D0
Authority
NO
Norway
Prior art keywords
prebiotic
aid
improve
immune system
carbohydrate formulation
Prior art date
Application number
NO20024011A
Other languages
English (en)
Norwegian (no)
Other versions
NO20024011L (no
Inventor
Ferdinand Haschke
Anne-Lise Carrie
Zdenek Kratky
Harriet Link-Amster
Florence Rochat
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of NO20024011D0 publication Critical patent/NO20024011D0/no
Publication of NO20024011L publication Critical patent/NO20024011L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733Fructosans, e.g. inulin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Confectionery (AREA)
  • Grain Derivatives (AREA)
NO20024011A 2000-03-01 2002-08-22 Karbohydratformulering (prebiotisk hjelpemiddel) for å forbedre immunforsvaret NO20024011L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00200735 2000-03-01
PCT/EP2001/001627 WO2001064225A1 (en) 2000-03-01 2001-02-14 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response

Publications (2)

Publication Number Publication Date
NO20024011D0 true NO20024011D0 (no) 2002-08-22
NO20024011L NO20024011L (no) 2002-08-22

Family

ID=8171132

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024011A NO20024011L (no) 2000-03-01 2002-08-22 Karbohydratformulering (prebiotisk hjelpemiddel) for å forbedre immunforsvaret

Country Status (21)

Country Link
US (2) US20030040492A1 (de)
EP (1) EP1261355B1 (de)
JP (1) JP4838477B2 (de)
KR (1) KR20020081375A (de)
CN (1) CN1243551C (de)
AR (1) AR027968A1 (de)
AT (1) ATE283697T1 (de)
AU (2) AU2001231746C1 (de)
BR (1) BR0108828A (de)
CA (1) CA2400969C (de)
DE (1) DE60107544T2 (de)
ES (1) ES2232591T3 (de)
HU (1) HUP0204546A3 (de)
IL (1) IL151280A0 (de)
MX (1) MXPA02008447A (de)
NO (1) NO20024011L (de)
PL (1) PL365136A1 (de)
PT (1) PT1261355E (de)
UA (1) UA73763C2 (de)
WO (1) WO2001064225A1 (de)
ZA (1) ZA200207849B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
US6319252B1 (en) 1999-07-23 2001-11-20 Mcdevitt Dennis System and method for attaching soft tissue to bone
KR20020043078A (ko) * 2000-12-01 2002-06-08 한인규 올리고당이 포함된 복합생균제
GB0229015D0 (en) 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
CN1863463B (zh) * 2003-06-23 2011-05-04 雀巢技术公司 用于促进肠道屏障成熟的营养组合物
US20050118299A1 (en) * 2003-12-01 2005-06-02 The Iams Company Companion animal compositions comprising short chain oligofructose
US20050118234A1 (en) * 2003-12-01 2005-06-02 The Iams Company Methods and kits related to administration of a fructooligosaccharide
US20050119222A1 (en) 2003-12-01 2005-06-02 The Iams Company Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use
NO320546B1 (no) * 2003-12-12 2005-12-19 Nova Biotics As Prebiotiske kombinasjonsprodukter
WO2006012536A2 (en) * 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8075934B2 (en) 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
US8287931B2 (en) 2005-06-30 2012-10-16 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
JP4889262B2 (ja) * 2005-08-19 2012-03-07 理研ビタミン株式会社 脂溶性薬剤組成物
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
EP2073643A2 (de) * 2006-10-18 2009-07-01 DSMIP Assets B.V. Verkapselung von hitze- und feuchtigkeitsempfindlichen substanzen
DE102007008664B4 (de) * 2007-02-20 2021-07-29 Vitacare Gmbh & Co. Kg Mittel zur Anwendung bei Fructoseintoleranz
EP2187756A1 (de) * 2007-08-24 2010-05-26 Barry Callebaut AG Verfahren und hiermit hergestelltes konfektprodukt
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
SI2285387T1 (sl) 2008-06-13 2016-02-29 N.V. Nutricia Prehrana za preprečevanje infekcij
EP2293802A4 (de) * 2008-06-25 2011-11-09 Ritter Pharmaceuticals Inc Lactosezusammensetzungen mit reduziertem lactosegehalt
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US8425955B2 (en) 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
EP2400839B1 (de) 2009-02-24 2016-09-07 Ritter Pharmaceuticals, Inc. Präbiotische formulierungen und verwendungsverfahren dafür
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
WO2010143940A1 (en) 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
CN102497868A (zh) 2009-07-15 2012-06-13 N.V.努特里奇亚 用于刺激免疫系统的不可消化低聚糖的混合物
PL2453901T3 (pl) 2009-07-15 2015-03-31 Nutricia Nv Fukozyloklaktoza jako identyczny z mlekiem kobiecym niestrawny oligosacharyd do leczenia i/lub zapobiegania infekcji wirusowych
WO2011060123A1 (en) 2009-11-12 2011-05-19 Nestec S.A. Nutritional composition for promoting gut microbiota balance and health
EP3202406A1 (de) 2010-04-28 2017-08-09 Ritter Pharmaceuticals, Inc. Präbiotische formulierungen und deren verwendungen
US20110293784A1 (en) 2010-05-28 2011-12-01 Anja Wittke Milk-based nutritional compositions
NL2007268C2 (en) 2011-08-16 2013-02-19 Friesland Brands Bv Nutritional compositions comprising human milk oligosaccharides and uses thereof.
WO2013149017A1 (en) * 2012-03-28 2013-10-03 Kansas State University Research Foundation Vaccine adjuvant
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
CN103330935A (zh) * 2013-06-17 2013-10-02 中山大学 果糖作为疫苗佐剂的应用
EP3079502A1 (de) 2013-11-04 2016-10-19 N.V. Nutricia Fermentierte formel mit nichtverdaulichen oligosacchariden
JP6637587B2 (ja) * 2015-08-04 2020-01-29 ズートツッカー アーゲー 副鼻腔炎に対するイヌリンの予防的使用
WO2019031961A1 (en) 2017-08-11 2019-02-14 N.V. Nutricia OLIGOSACCHARIDE OF HUMAN MILK TO IMPROVE PHYSICAL IMMUNE CONDITION
EP3679057A1 (de) * 2017-09-08 2020-07-15 Evelo Biosciences, Inc. Extrazelluläre vesikel aus prevotella
EP3678693A1 (de) 2017-09-08 2020-07-15 Evelo Biosciences, Inc. Bakterielle extrazelluläre vesikel
JP7469037B2 (ja) * 2019-02-28 2024-04-16 森永乳業株式会社 発酵乳
CN111529703B (zh) * 2020-06-17 2023-09-15 湖南循天然营养有限公司 一种组合物及其制备方法与在制备免疫佐剂中的应用
CN113876935B (zh) * 2021-10-19 2025-11-04 深圳市红瑞生物科技有限公司 一种治疗宠物肠道疾病的组合物及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3689071T2 (de) 1985-10-31 1994-02-10 Univ Australian Immunheilbehandlung.
US5422346A (en) 1988-01-06 1995-06-06 California Natural Products Instant dried dahlia inulin juice and its method of production and usage
DE4341780A1 (de) * 1993-12-08 1995-06-14 Suedzucker Ag Hydrierte Fructooligosaccharide
DE69520528T2 (de) * 1994-06-14 2001-09-27 Raffinerie Tirlemontoise, S.A. Verwendung einer Zusammensetzung enthaltend Inulin oder Oligofructose als Antikrebsmittel
ATE169456T1 (de) * 1996-12-23 1998-08-15 Sitia Yomo Spa Lyophilisierte, lebende bakerien enthaltende nahrungszusammensetzung
US6203797B1 (en) 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome

Also Published As

Publication number Publication date
JP4838477B2 (ja) 2011-12-14
AU2001231746C1 (en) 2005-10-06
US7101553B2 (en) 2006-09-05
AR027968A1 (es) 2003-04-16
BR0108828A (pt) 2002-12-10
UA73763C2 (en) 2005-09-15
ZA200207849B (en) 2003-12-30
AU2001231746B2 (en) 2004-12-23
CN1243551C (zh) 2006-03-01
PT1261355E (pt) 2005-02-28
JP2003533438A (ja) 2003-11-11
AU3174601A (en) 2001-09-12
HUP0204546A3 (en) 2003-10-28
MXPA02008447A (es) 2002-12-13
PL365136A1 (en) 2004-12-27
ATE283697T1 (de) 2004-12-15
EP1261355A1 (de) 2002-12-04
NO20024011L (no) 2002-08-22
CA2400969A1 (en) 2001-09-07
US20030040492A1 (en) 2003-02-27
IL151280A0 (en) 2003-04-10
WO2001064225A1 (en) 2001-09-07
ES2232591T3 (es) 2005-06-01
KR20020081375A (ko) 2002-10-26
HUP0204546A2 (en) 2003-05-28
EP1261355B1 (de) 2004-12-01
CA2400969C (en) 2011-04-19
HK1051650A1 (en) 2003-08-15
DE60107544T2 (de) 2005-12-15
US20040191234A1 (en) 2004-09-30
CN1422158A (zh) 2003-06-04
DE60107544D1 (de) 2005-01-05

Similar Documents

Publication Publication Date Title
NO20024011D0 (no) Karbohydratformulering (prebiotisk hjelpemiddel) for å forbedre immunforsvaret
NO20005119D0 (no) Interaktivt system
EP1228535A4 (de) Gegenüberliegende halbleiterbauteile
DE10196919T1 (de) Elektromagnetisch gekoppeltes Bussystem
DE60126089D1 (de) Verabreichungssystem
DE60010791D1 (de) Hebelartiger Steckverbinder
DE60000084D1 (de) Hebelsteckverbinder
ID29737A (id) Penghubung untuk kabel di atas tanah
GB2364642B (en) Compositions for enhancing the immune response
NO20010842D0 (no) Forbindelseselement for sammenkobling av to komponenter
GB2361782B (en) Improvements relating to computer systems
DE50015381D1 (de) Retardersystem
ATE289720T1 (de) Transaktionszertifizierung
EP1313839A4 (de) Immunsystem steigernde zusammensetzungen
IT1310385B1 (it) Dispositivo per migliorare la respirazione.
AU2001277213A1 (en) High-availability shared-memory system
GB0019851D0 (en) System for property transactions
IT1305996B1 (it) Dispositivo per spostare mobili.
IT1310241B1 (it) Dispositivo di collegamento per almeno due componenti di mobile dacollegare.
IT1317266B1 (it) Impianto di decatissaggio con dispositivo per sostituire la telatecnica.
ES1044282Y (es) Dispositivo para apagar cigarrillos.
IT1319699B1 (it) Dispositivo per prevenire la formazione di rughe.
ITRM990518A0 (it) Perfezionamenti ai girarrosti.
DK1165069T3 (da) Synergistisk antitumorpræparat
FI4237U1 (fi) Imurilaitteisto